STAAR Surgical Company (STAA) Financial Statements
STAAR Surgical Company (STAA) reported trailing twelve-month revenue of $339.6M (up 51.3% year on year) and net income of $3.8M as of 2026-07-03, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$6.7M.
Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason
STAASTAAR Surgical CompanyFollow STAA — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jul 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Jan 14 | FY2014 Jan 15 | FY2015 Jan 16 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Jan 20 | FY2020 Jan 21 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Jan 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 62.8 | 63.8 | 72.2 | 75.0 | 77.1 | 82.4 | 90.6 | 124.0 | 150.2 | 163.5 | 230.5 | 239.4 | 322.4 | 313.9 | 239.4 | 339.6 | |
| Gross profit | 42.4 | 44.3 | 50.3 | 48.8 | 52.7 | 58.4 | 64.3 | 91.5 | 112.0 | 118.4 | 178.6 | 223.4 | 252.7 | 239.6 | 182.4 | 260.2 | |
| Research & development | 5.9 | 6.4 | 6.7 | 12.4 | 14.8 | 20.7 | 20.0 | 22.0 | 25.3 | 31.9 | 33.9 | 36.0 | 40.5 | 45.3 | 40.1 | 38.3 | |
| Operating income | 2.8 | -1.2 | 0.7 | -8.0 | -5.3 | -12.7 | -3.6 | 6.6 | 11.9 | 6.8 | 33.3 | 43.8 | 28.1 | -12.6 | -91.7 | 13.7 | |
| Pre-tax income | 2.7 | -0.5 | 1.1 | -8.6 | -5.6 | -12.4 | -2.3 | 6.6 | 13.0 | 8.3 | 31.3 | 45.6 | 33.7 | -9.1 | -82.3 | 17.4 | |
| Income tax | 1.4 | 1.2 | 0.7 | -0.3 | 0.9 | -0.3 | -0.2 | 1.7 | -1.0 | 2.4 | 3.8 | 5.9 | 12.3 | 11.2 | -1.8 | 13.5 | |
| Net income | 1.3 | -1.8 | 0.4 | -8.4 | -6.5 | -12.1 | -2.1 | 5.0 | 14.0 | 5.9 | 27.5 | 39.7 | 21.3 | -20.2 | -80.4 | 3.8 | |
| Diluted EPS ($) | 0.04 | -0.05 | 0.01 | -0.22 | -0.17 | -0.30 | -0.05 | 0.11 | 0.30 | 0.12 | 0.56 | 0.80 | 0.43 | -0.41 | -1.62 | 0.08 | |
| Diluted shares (mn) | 36.9 | 36.3 | 38.6 | 38.1 | 39.3 | 40.3 | 41.0 | 45.3 | 46.9 | 48.0 | 49.5 | 49.4 | 49.4 | 49.1 | 49.6 | — |
USD millions · SEC XBRL
STAAR Surgical Company — questions
- What is STAAR Surgical Company's revenue?
- $339.6M over the twelve months to 2026-07-03, up 51.3% year on year, from its 10-Q and 10-K filings.
- What is STAAR Surgical Company's net income?
- $3.8M over the twelve months to 2026-07-03.
- What is STAAR Surgical Company's free cash flow?
- -$6.7M over the twelve months to 2026-07-03.
- What are STAAR Surgical Company's diluted earnings per share?
- $0.08 over the twelve months to 2026-07-03.
Every figure on this page comes from STAAR Surgical Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.